AARS1 lactylates p53 at specific lysine residues (K120 and K139), which impairs p53’s DNA binding capacity and liquid–liquid phase separation (LLPS), thereby inhibiting the tumor-suppressing function of p53 [70]. Here, TP53 is linked to neoplasm.